Psyence Biomedical Ltd. (PBM) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -662 | -251.46K | -251.43K | -550.22K | -86.26K | -91.94K | -125.03K | -216.38K | -819.68K | -6.88K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 99.23% | -173.5% | -101.09% | -154.29% | 89.48% | -1235.55% | - | - | - | - |
| Net Income | -24.76K | -647.77K | -62.84K | -33.12K | 2.25M | 766.84K | 2.04M | 2.95M | 8.31M | -45.06K |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 159 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 24.11K | 90.71K | 483.4K | -1.51M | -1.93M | -929.97K | -2.34M | -3.28M | -8.56M | -6.83K |
| Working Capital Changes | -167 | 305.6K | -671.98K | 989.18K | -404.14K | 71.19K | 167.99K | 110.53K | -564.88K | 45K |
| Change in Receivables | -13 | 0 | 0 | 767.91K | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -4 | 4.21M | -247.5K | 242.86M | 0 | 0 | 0 | 0 | -255M | 0 |
| Capital Expenditures | -4 | -4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 738 | -3.88M | 492.77K | -242.43M | 1.45K | 0 | 0 | 0 | 256.46M | 6.83K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -31.83K | 31.83K |
| Equity Issued (Net) | 0 | -4.31M | 0 | -243.11M | 0 | 0 | 0 | 0 | 256.49M | -25K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -4.31M | 0 | -243.11M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 738 | 430K | 492.77K | 685K | 1.45K | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 73 | 78.37K | -6.15K | -112.72K | -86.26K | -91.94K | -125.03K | -216.38K | 638.37K | -57 |
| Free Cash Flow | -665 | -251.46K | -251.43K | -550.22K | -86.26K | -91.94K | -125.03K | -216.38K | -819.68K | -6.88K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 99.23% | -173.51% | -101.09% | -154.29% | 89.48% | -1235.55% | - | - | - | - |
| FCF per Share | -0.00 | -0.03 | -0.03 | -0.05 | -0.00 | -0.00 | -0.00 | -0.01 | -0.03 | -0.00 |
| FCF Conversion (FCF/Net Income) | 0.00x | 0.29x | 4.00x | 22.47x | -0.04x | -0.12x | -0.06x | -0.07x | -0.10x | 0.15x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |